SYNFLORIX

Valsts: Indonēzija

Valoda: indonēziešu

Klimata pārmaiņas: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Aktīvā sastāvdaļa:

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D

Pieejams no:

SMITHKLINE BEECHAM PHARMACEUTICALS - Indonesia

SNN (starptautisko nepatentēto nosaukumu):

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D

Deva:

1 µG PS1 - 1.6 µG PD MG /3 µG PS4 - 5.1 µG PD MG /1 µG PS5 - 1.0 µG PD MG /1 µG PS6B - 0.8 µG PD M

Zāļu forma:

SUSPENSI

Vienības iepakojumā:

DUS, 1 PREFILLED SYRINGE @ 0,5 ML (1 DOSIS) + 1 JARUM SUNTIK

Ražojis:

GlaxoSmithKline Biologicals SA - Belgium

Autorizācija datums:

2020-03-25